1. Home
  2. HALO vs PSN Comparison

HALO vs PSN Comparison

Compare HALO & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • PSN
  • Stock Information
  • Founded
  • HALO 1998
  • PSN 1944
  • Country
  • HALO United States
  • PSN United States
  • Employees
  • HALO N/A
  • PSN N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • PSN EDP Services
  • Sector
  • HALO Health Care
  • PSN Technology
  • Exchange
  • HALO Nasdaq
  • PSN Nasdaq
  • Market Cap
  • HALO 7.4B
  • PSN 6.8B
  • IPO Year
  • HALO N/A
  • PSN 2019
  • Fundamental
  • Price
  • HALO $54.54
  • PSN $66.16
  • Analyst Decision
  • HALO Buy
  • PSN Buy
  • Analyst Count
  • HALO 9
  • PSN 11
  • Target Price
  • HALO $63.56
  • PSN $87.44
  • AVG Volume (30 Days)
  • HALO 3.3M
  • PSN 1.6M
  • Earning Date
  • HALO 05-06-2025
  • PSN 04-30-2025
  • Dividend Yield
  • HALO N/A
  • PSN N/A
  • EPS Growth
  • HALO 55.40
  • PSN 50.29
  • EPS
  • HALO 3.76
  • PSN 2.35
  • Revenue
  • HALO $1,084,306,000.00
  • PSN $6,769,260,000.00
  • Revenue This Year
  • HALO $25.77
  • PSN $5.09
  • Revenue Next Year
  • HALO $18.01
  • PSN $4.47
  • P/E Ratio
  • HALO $14.51
  • PSN $28.18
  • Revenue Growth
  • HALO 25.64
  • PSN 16.61
  • 52 Week Low
  • HALO $42.01
  • PSN $54.56
  • 52 Week High
  • HALO $70.51
  • PSN $114.68
  • Technical
  • Relative Strength Index (RSI)
  • HALO 44.48
  • PSN 51.78
  • Support Level
  • HALO $52.43
  • PSN $66.51
  • Resistance Level
  • HALO $54.26
  • PSN $68.53
  • Average True Range (ATR)
  • HALO 3.42
  • PSN 1.78
  • MACD
  • HALO -0.49
  • PSN 0.08
  • Stochastic Oscillator
  • HALO 30.60
  • PSN 60.58

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

Share on Social Networks: